Letter to the Editor: Tumor Lysis Syndrome During Selpercatinib Treatment in a Patient with Medullary Thyroid Cancer.
Thyroid
; 33(9): 1130-1132, 2023 09.
Article
in En
| MEDLINE
| ID: mdl-37463111
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Tumor Lysis Syndrome
/
Carcinoma, Neuroendocrine
Type of study:
Etiology_studies
Limits:
Humans
Language:
En
Journal:
Thyroid
Journal subject:
ENDOCRINOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Italy
Country of publication:
United States